CHA Biotech Co. Ltd (085660) — Long-term Investment Intensity
CHA Biotech Co. Ltd (085660) has a Long-term Investment Intensity of 10.6% as of September 2019. Long-term investments of ₩122.58 Billion represent 10.6% of total assets of ₩1.16 Trillion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check cash flow reinvestment rate of CHA Biotech Co. Ltd to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
CHA Biotech Co. Ltd Long-term Investment Intensity (2014–2018)
This chart shows how CHA Biotech Co. Ltd's Long-term Investment Intensity has evolved across 5 annual periods from 2014 to 2018. As of September 2019, the intensity stands at 10.6%, reflecting long-term investments of ₩122.58 Billion against total assets of ₩1.16 Trillion KRW. Explore 085660 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for CHA Biotech Co. Ltd (2014–2018)
The table below presents the year-by-year Long-term Investment Intensity for CHA Biotech Co. Ltd from 2014 to 2018, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see CHA Biotech Co. Ltd stock valuation.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 6.3% | ₩59.53 Billion | ₩947.53 Billion | ▲ +0.9 pp |
| 2017 | 5.3% | ₩42.35 Billion | ₩793.61 Billion | ▲ +3.0 pp |
| 2016 | 2.4% | ₩18.08 Billion | ₩768.93 Billion | ▲ +0.8 pp |
| 2015 | 1.5% | ₩9.89 Billion | ₩644.83 Billion | ▼ -1.1 pp |
| 2014 | 2.6% | ₩16.23 Billion | ₩620.88 Billion | — |